Zenas BioPharma, Inc. (ZBIO)
NASDAQ·Healthcare·Biotechnology
$18.19
-2.15%
Mkt Cap $825.45M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $13.33M | — | — | -$1.00 | -$1.10 | -9.85% | — | — |
| Q4 2025 Nov 12, 2025 | $28.75M | — | — | -$0.87 | -$1.22 | -40.23% | — | — |
| Q3 2025 Aug 12, 2025 | $3.75M | — | — | -$1.02 | -$1.25 | -22.55% | — | — |
| Q2 2025 May 15, 2025 | $1.25M | $10.00M | +700.00% | -$1.11 | -$0.80 | +27.93% | — | — |
| Q1 2025 Mar 25, 2025 | — | $5.00M | — | -$0.92 | -$3.99 | -333.70% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$9.33 | -$5.02 | +46.20% | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$0.99 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.73 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.64 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | $50.00M | — | — | $0.85 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.76 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.50 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.50 | — | — | — |